Investing Profile

Greg Yap

InvestorVC

Partner at Menlo Ventures

menlovc.com/greg-yapPalo Alto, California

Your Intro Paths to Greg Yap

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Greg is a member of

GE Network

107 CONNECTIONS

The Aspen Institute Network

62 CONNECTIONS

Menlo Ventures Network

48 CONNECTIONS

H1 Network

11 CONNECTIONS

Find Greg Yap on

Current Investing Position

Menlo Ventures Partner

Investment Range

$8.0M - $15.0M

Sweet Spot

$12.0M

Investments On Record

Current Fund Size

$500M

Greg Yap is on these Sector & Stage Rankings

Medical Devices (Seed)BioTech (Series B)Medical Devices (Series B)Medical Devices (Series A)BioTech (Seed)BioTech (Series A)Health IT (Series A)Health & Hospital Services (Series B)Health & Hospital Services (Series A)San Francisco Bay Area Digital Health (Series B)Health IT (Seed)Health IT (Series B)Digital Health (Series A)Digital Health (Seed)Health & Hospital Services (Seed)

Greg Yap's Investments On Record (21)

Company	StageDateRound Size	Total Raised
Chai Discovery	Series CJul 2026$400M Series BDec 2025$130M Series AAug 2025$70M	$630M
Co-investors: Hemant Taneja (General Catalyst), Nina Achadjian (Index Ventures), Patrick Grady (Sequoia Capital), Elena Viboch (General Catalyst), Fred Ehrsam (Paradigm), Lachy Groom (Physical Intelligence), Annie Lamont (Oak HC/FT), Ilya Fushman (Kleiner Perkins), Zavain Dar (Dimension Capital), Nitesh Banta (Getaround)
Aurora Therapeutics	SeedJan 2026$16M	$16M
Co-investors: Johnny Hu (Menlo Ventures)
Cartwheel	Series BAug 2025$35M Series ASep 2023$20M	$75M
Co-investors: Reva Nohria (General Catalyst), Minnie Ingersoll (TenOneTen Ventures), Jomayra Herrera (Reach Capital), Craig Cummings (Moonshots Capital), Raoul Maier (Eudemian Ventures, LLC), Samara Hernandez (Chingona Ventures), Lainy Painter (Craft Ventures), Sean Whitney (Craft Ventures), Elena (Lainy) Painter (Craft Ventures), Akshay Kothari (Sdl Ventures), Daniel Levine (Accel-KKR), Drew Houston, Amjad Masad
Heidi Health	Series AMar 2025$17M	$88M
Co-investors: Brian Keil (Chestnut Street Ventures), Taylor Brandt (Headline (formerly e.ventures)), Sri Chandrasekar (Point72 Ventures), Michael Tolo (Blackbird Ventures)
Clear Labs	Series DJan 2025$30M Series CMay 2021$60M Series UnknownMay 2020$21M Series BOct 2018$21M	$170M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Aydin Senkut (Felicis Ventures), Karl Handelsman (Codon Capital), Miguel Valls (Alta Life Sciences), Chris Sklarin (Castor Ventures (an Alumni Ventures Fund)), Kyle Kurpinski (Tencent Holdings)
Vilya	Series AJun 2024$21M	$71M
Co-investors: Steven Gillis (ARCH Venture Partners), Robert Nelsen (ARCH Venture Partners)
Xaira Therapeutics	Series AApr 2024$1B	$1B
Co-investors: Scott Gottlieb (New Enterprise Associates (NEA)), Roelof Botha (Sequoia Capital), Vikram Bajaj (Foresite Capital), Robert Nelsen (ARCH Venture Partners)
DELFI Diagnostics	Series BJul 2022$230M Series AJan 2021$100M SeedAug 2019$6M	$330M
Co-investors: Rishi Gupta (OrbiMed), Justin Kao (DFJ Growth)

Greg Yap's Experience

Investor Xaira Therapeutics2024 - Present

Board Member & Investor Vilya2023 - Present

Board Member & Investor Cartwheel2023 - Present

Board Member & Investor Koala Health2022 - Present

Investor Scribe Therapeutics2021 - Present

Board Member & Investor Ophelia2021 - Present

Board Member & Investor Particle Health2020 - Present

Board Member & Investor H12020 - Present

Board Observer & Investor Genesis Therapeutics2020 - Present

Health Innovators Fellow The Aspen Institute2019 - Present

Board Member & Investor Clear Labs2019 - Present

Investor Benchling2019 - Present

Investor Encoded Therapeutics Inc.2019 - Present

Board Member & Investor Riva Health2019 - Present

Board Member & Investor Delfi Diagnostics2019 - Present

Board Member & Investor Epiodyne2018 - Present

Investor Pliant Therapeutics2018 - Present

Partner Menlo Ventures2017 - Present

Investor Recursion2017 - Present

Board Member Outward Bound California2013 - Present

Entrepreneur in Residence Illumina Ventures2016 - 2017

CEO & Co-founder PyrAmes2016 - 2017

CEO & Co-founder Biodesy (now BlueLight Therapeutics, Inc.)2013 - 2016

Entrepreneur in Residence GE2013 - 2013

Lifecycle Leader (SVP), Advanced Assays Ventana Medical Systems2010 - 2013

Lifecycle Leader (SVP), Advanced Assays Roche Diagnostics2010 - 2013

Chief Operating Officer CellPoint Diagnostics2008 - 2009

Vice President, Molecular Diagnostics Affymetrix2006 - 2008

Vice President, DNA Products Affymetrix2001 - 2005

Director, Business Development Affymetrix1997 - 1999

Business Analyst McKinsey1995 - 1997

Investors who invest with Greg Yap

Scouts & Angels Affiliated With Greg Yap